AbaCityBlog
Friday, August 15, 2025
  • Login
  • HOME
  • Student Guides
  • Scholarships
  • Travel
  • Tech
  • Business
  • Make Money Online
  • Gadgets
  • DIY
No Result
View All Result
  • HOME
  • Student Guides
  • Scholarships
  • Travel
  • Tech
  • Business
  • Make Money Online
  • Gadgets
  • DIY
No Result
View All Result
AbaCityBlog
No Result
View All Result

Drug to treat hair loss condition alopecia is FINALLY approved by the FDA after amazing clinical trial

June 15, 2022
in World News

A drug to treat severe alopecia, an autoimmune disorder that causes hair loss, has been approved by the Food and Drug Administration (FDA).

The condition, which has become more widely known, affects more than 300,000 people in the United States every year.

Drug to treat hair loss condition alopecia is FINALLY approved by the FDA after amazing clinical trial
Drug to treat hair loss condition alopecia is FINALLY approved by the FDA after amazing clinical trial

On Monday, the FDA approved a drug called baricitinib as the first oral tablet for treating severe alopecia areata.

Alopecia causes either temporary or permanent hair loss that can affect any hair-bearing site of the body, leading to emotional distress.

The approval for use against alopecia was based on the results of two randomized, controlled clinical trials involving a total 1,200 adults with severe alopecia.

Baricitinib, which is made by US pharmaceutical company Eli Lilly and known by the trade name Olumiant, belongs to a class of drugs called Janus kinase inhibitors. It works by interfering with the cellular pathway that leads to inflammation.

Drug to treat hair loss condition alopecia is FINALLY approved by the FDA after amazing clinical trial
Baricitinib is made by US pharmaceutical company Eli Lilly and known by the trade name Olumiant

‘Access to safe and effective treatment options is crucial for the significant number of Americans affected by severe alopecia,’ said FDA official Kendall Marcus in a statement.

‘Today’s approval will help fulfill a significant unmet need for patients with severe alopecia areata.’

Each trial split participants into three groups: a placebo group, a group that received a two-milligram dose every day, and a group that received a four-milligram dose every day.

Drug to treat hair loss condition alopecia is FINALLY approved by the FDA after amazing clinical trial
Drug to treat hair loss condition alopecia is FINALLY approved by the FDA after amazing clinical trial

After 36 weeks, almost 40 percent of those on the higher dose grew back 80 percent of their scalp hair, compared to around 23 percent of the lower dose group, and five percent of the placebo group.

Around 45 percent of people in the higher dose group also saw significant eyebrow and eyelash regrowth.

The most common side effects included upper respiratory tract infections, headaches, acne, high cholesterol, and increase of an enzyme called creatine phosphokinase.

Prior treatments for alopecia included topical or oral drugs, but these have been considered experimental and none was approved.

Baricitinib was previously approved for treatment of rheumatoid arthritis, and during the Covid pandemic its license was extended to the treatment of hospitalized Covid patients.

Tags: AlopeciaFDAHair LossOlumiant
Next Post

Warning: Undefined array key "jnews-75x75" in /home/abacsskt/public_html/wp-content/themes/jnews/class/Image/Image.php on line 114

Warning: Trying to access array offset on null in /home/abacsskt/public_html/wp-content/themes/jnews/class/Image/ImageLazyLoad.php on line 105
Abia State House of Assembly Plenary for Monday, 22nd March, 2021

Abia State House of Assembly Plenary for Wednesday, 15th June, 2022


Warning: Undefined array key "jnews-75x75" in /home/abacsskt/public_html/wp-content/themes/jnews/class/Image/Image.php on line 114

Warning: Trying to access array offset on null in /home/abacsskt/public_html/wp-content/themes/jnews/class/Image/ImageLazyLoad.php on line 105
Abia Speaker Pays Condolence Visit to the Family of Late Deacon Michael Nwoke

Abia Speaker Pays Condolence Visit to the Family of Late Deacon Michael Nwoke

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • About us
  • Advertise
  • Contact us
  • Privacy Policy
Call us: +2347038111972

© 2023 Abacity Blog Media

Social icon element need JNews Essential plugin to be activated.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Contact us
  • Advertise
  • Aba News
  • #OffBeat

© 2023 Abacity Blog Media